570,556 snapshots · latest May 3, 2026
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
386,223 snapshots · latest Apr 14, 2026
243,880 snapshots · latest Apr 28, 2026
Biodisponibilité et bioéquivalence ICH M9 Dispense de démonstration de bioéquivalence fondée sur le système de classification biopharmaceutique Ligne directrice: Conduite et analyse des études de biodisponibilité comparatives [2018-06-08] Normes en matière d'études de…
Examen de la réglementation des essais cliniques : mesures ciblées pour un cadre renforcé (Version PDF - 102 Ko) Contact: Examen du cadre de réglementation des essais cliniques Direction générale des produits de santé et des aliments Santé Canada Mars 2008 Table des matières 1…
Quarterly Financial Report for the Quarter Ended December 31, 2025 Table of contents Introduction Highlights of fiscal quarter and fiscal year-to-date results Risk and uncertainties Significant changes related to personnel, operations and programs Annex A - Statement of…
Annual Report on Fighting Against Forced Labour and Child Labour in Supply Chains For the Financial Reporting Period: April 1, 2024, to March 31, 2025 General Overview This annual report is prepared in accordance with the requirements of the Fighting Against Forced Labour and…
Reporting obligations under the Fighting Against Forced Labour and Child Labour in Supply Chains Act Report submitted by the Canadian Institutes of Health Research (CIHR) for Fiscal Year 23/24 On this page Part 1: Identifying Information Part 2: Report Contents 2.1 Structure,…
Annexe 7 aux lignes directrices sur les bonnes pratiques de fabrication - certaines drogues en vente libre (GUI-0066) : Aperçu Aperçu Orientation Définitions Références Télécharger le format de rechange (Format PDF, 735 ko, 26 pages) Organisation : Santé Canada Date publiée : 29…
Summary of Pharmaceutical Survey Findings on R&D Spending and Investments by Rx&D Members - 2010 Canada's Research-Based Pharmaceutical Companies (Rx&D) (the " Company" ) on behalf of the Steering Committee, made up of members from: Rx&D; Industry Canada; Patented Medicine Prices…
Canadian Institutes of Health Research – 2017 to 2018 Fees Report At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada’s health research investment agency, we collaborate with partners and researchers to support the…
2012-13 Annual Report on the Administration of the Privacy Act April 1, 2012 – March 31, 2013 Introduction The Canadian Institutes of Health Research (CIHR) is pleased to submit to Parliament its annual report on the administration of the Privacy Act for the fiscal year…
2011-12 Annual Report on the Administration of the Privacy Act April 1, 2011 – March 31, 2012 Introduction The Canadian Institutes of Health Research (CIHR) is pleased to submit to Parliament its annual report on the administration of the Privacy Act for the fiscal year…
Early release: coverage and features are still expanding.
